Market Tracker

02/12 5:16pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

0.8485
Delayed Data
As of Feb 12
 +0.0385 / +4.75%
Today’s Change
0.80
Today|||52-Week Range
10.05
-29.88%
Year-to-Date

Today’s Trading

Previous close0.81
Today’s open0.82
Day’s range0.80 - 0.86
Volume77,945
Average volume (3 months)737,031
Market cap$20.6M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-4.51%
Earnings growth (this year)+8.39%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc0.000.00%
ENZNEnzon Pharmaceutical...+0.06+14.45%
EYEGEyeGate Pharmaceutic...-0.06-2.16%
--Luckycom Inc0.000.00%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$32.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts